Fundraising Fox

VetDC

Castle Rock, US · Founded 2012 · Delaware corporation · 1 known investors

A veterinary pharmaceutical company developing Rabacfosadine, an acyclic nucleotide analogue for treating lymphoma in dogs and cats.

BiotechMedical Devices

Founders & leadership

SB
Steve Bryan WarneckeExecutive
SJ
Steven J RoyNamed on SEC filing

Board

TR
T. Richard FortBoard director
ML
Mark LupaBoard director

Investors · 1

Keiretsu ForumSan Francisco · $250K – $2M

Reported raises · per SEC filings

Form D private placements

$2.7M disclosed across 2 rounds · 2014–2015

▶$2.1MraisedMar 2015 · 35 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven J RoyExecutive Officer, Director
  • T. Richard FortDirector
  • Steve Bryan WarneckeExecutive Officer, Director
  • Mark LupaDirector
Offering amount
$6M
Amount sold
$2.1M
Minimum investment
$10K
Proceeds to insiders
$193K
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$587.3KraisedNov 2014 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • T. Richard FortDirector
  • Steve Bryan WarneckeExecutive Officer, Director
  • Steven J RoyExecutive Officer, Director
Offering amount
$3.3M
Amount sold
$587.3K
Minimum investment
$10K
First sale
Sep 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
ImpriMed17 shared keywordsImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.

Companies competing with VetDC for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

CSU spinoff VetDC raises $2.1M to help commercialize canine cancer drug – BizWestbizwest.com · Apr 2015VetDC, Inc. Raises $1.5 Million to Advance VDC-1101 for Canine Lymphoma | Fierce Biotechfiercebiotech.com · Nov 2012Colorado Institute Awards Funding To VetDCveterinarypracticenews.com · Jun 2011

Frequently asked questions

What does VetDC do?
A veterinary pharmaceutical company developing Rabacfosadine, an acyclic nucleotide analogue for treating lymphoma in dogs and cats.
Who are VetDC's investors?
VetDC's investors include Keiretsu Forum.
How much funding has VetDC raised?
VetDC has disclosed $2.7M raised across 2 rounds.
Where is VetDC headquartered?
VetDC is headquartered in Castle Rock, US.